LYNNTECH INC. — Department of Homeland Security SBIR Phase I: DHS211-011

Description

There is an unmet need to develop multiplex surveillance systems that can detect the three classes of biological threat agents: bacteria, viruses, and toxins. These systems need to be portable, economical, and have low power requirements, rapid turnaround times, and adaptability.It is critical that the systems can be easily modified to address new threat agents as they arise.A majority of the current detection systems are either nucleic acid- or protein-based. Many of these methods require laboratory space, expensive instrumentation, and trained personnel.Unfortunately, nucleic acid-based methods cannot be used to detect toxins.<br/> Lynntech proposes to develop a point-of-care detection assay that will detect multiple biological threat agents, namely bacteria, viruses, and toxins.Lynntech's proposed technology will not rely on nucleic acids or large proteins to detect these biothreats.Our system will offer multiple advantages over current methods. For example, the Lynntech system will be economical, will exhibit exquisite sensitivity and specificity, will be light weight and portable, and will not require sophisticated instrumentation or highly trained personnel.We believe that our biothreat detection assay will have broad appeal to government and civilian populations and, therefore, have solid commercial potential.